Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Inotrem closes €18mm Series A round to support sepsis candidate

Executive Summary

In the largest European Series A financing so far this year, French biotech Inotrem SA closed an €18mm ($25mm) first round led by Edmond de Rothschild Investment Partners and Sofinnova Partners, which each add a board member and were joined by Biomed Invest and Inserm Transfert Initiative.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies